Environment and the inflammatory bowel diseases - PubMed (original) (raw)
Review
Environment and the inflammatory bowel diseases
Alexandra Frolkis et al. Can J Gastroenterol. 2013 Mar.
Abstract
Inflammatory bowel diseases (IBD), which consists of Crohn disease and ulcerative colitis, are chronic inflammatory conditions of the gastrointestinal tract. In genetically susceptible individuals, the interaction between environmental factors and normal intestinal commensal flora is believed to lead to an inappropriate immune response that results in chronic inflammation. The incidence of IBD have increased in the past century in developed and developing countries. The purpose of the present review is to summarize the current knowledge of the association between environmental risk factors and IBD. A number of environmental risk factors were investigated including smoking, hygiene, microorganisms, oral contraceptives, antibiotics, diet, breastfeeding, geographical factors, pollution and stress. Inconsistent findings among the studies highlight the complex pathogenesis of IBD. Additional studies are necessary to identify and elucidate the role of environmental factors in IBD etiology.
Les maladies inflammatoires de l’intestin (MII), qui incluent la maladie de Crohn et la colite ulcéreuse, sont des maladies inflammatoires chroniques du tube digestif. Chez les personnes qui y sont génétiquement susceptibles, on pense que l’interaction entre les facteurs environnementaux et la flore commensale intestinale normale entraîne une réponse immunitaire inadéquate qui suscite une inflammation chronique. L’incidence de MII a augmenté depuis un siècle dans les pays industrialisés et les pays en développement. La présente analyse vise à résumer les connaissances actuelles sur l’association entre les facteurs de risque environnementaux et les MII. Les chercheurs ont exploré plusieurs facteurs de risque environnementaux, y compris le tabagisme, l’hygiène, les microorganismes, les contraceptifs oraux, les antibiotiques, le régime, l’allaitement, les facteurs géographiques, la pollution et le stress. Les résultats contradictoires entre les études font ressortir la pathogenèse complexe des MII. D’autres études s’imposent pour déterminer et clarifier le rôle des facteurs environnementaux dans l’étiologie des MII.
Similar articles
- Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.
Abegunde AT, Muhammad BH, Bhatti O, Ali T. Abegunde AT, et al. World J Gastroenterol. 2016 Jul 21;22(27):6296-317. doi: 10.3748/wjg.v22.i27.6296. World J Gastroenterol. 2016. PMID: 27468219 Free PMC article. Review. - The Search for Causative Environmental Factors in Inflammatory Bowel Disease.
Rogler G, Zeitz J, Biedermann L. Rogler G, et al. Dig Dis. 2016;34 Suppl 1:48-55. doi: 10.1159/000447283. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548430 - Environmental risk factors for inflammatory bowel disease.
Molodecky NA, Kaplan GG. Molodecky NA, et al. Gastroenterol Hepatol (N Y). 2010 May;6(5):339-46. Gastroenterol Hepatol (N Y). 2010. PMID: 20567592 Free PMC article. - Inflammatory bowel disease: the role of environmental factors.
Danese S, Sans M, Fiocchi C. Danese S, et al. Autoimmun Rev. 2004 Jul;3(5):394-400. doi: 10.1016/j.autrev.2004.03.002. Autoimmun Rev. 2004. PMID: 15288007 Review. - [Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy)].
Jantchou P, Monnet E, Carbonnel F. Jantchou P, et al. Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):859-67. doi: 10.1016/s0399-8320(06)73333-4. Gastroenterol Clin Biol. 2006. PMID: 16885870 Review. French.
Cited by
- Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells.
Chiu YH, Lu YC, Ou CC, Lin SL, Tsai CC, Huang CT, Lin MY. Chiu YH, et al. BMC Microbiol. 2013 Aug 10;13:190. doi: 10.1186/1471-2180-13-190. BMC Microbiol. 2013. PMID: 23937116 Free PMC article. - Evaluating the influence of environmental risk factors on inflammatory bowel diseases: a case-control study.
Riahi R, Abdi S, Ashtari S, Malekpour H. Riahi R, et al. Gastroenterol Hepatol Bed Bench. 2023;16(3):307-318. doi: 10.22037/ghfbb.v16i2.2576. Gastroenterol Hepatol Bed Bench. 2023. PMID: 37767328 Free PMC article. - The role of Klebsiella in Crohn's disease with a potential for the use of antimicrobial measures.
Rashid T, Ebringer A, Wilson C. Rashid T, et al. Int J Rheumatol. 2013;2013:610393. doi: 10.1155/2013/610393. Epub 2013 Oct 10. Int J Rheumatol. 2013. PMID: 24223596 Free PMC article. Review. - Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches.
Rahman SU, Li Y, Huang Y, Zhu L, Feng S, Wu J, Wang X. Rahman SU, et al. Inflammopharmacology. 2018 Apr;26(2):319-330. doi: 10.1007/s10787-018-0462-4. Epub 2018 Mar 12. Inflammopharmacology. 2018. PMID: 29532213 Review. - Inflammatory bowel disease: can omega-3 fatty acids really help?
Barbalho SM, Goulart Rde A, Quesada K, Bechara MD, de Carvalho Ade C. Barbalho SM, et al. Ann Gastroenterol. 2016 Jan-Mar;29(1):37-43. Ann Gastroenterol. 2016. PMID: 26752948 Free PMC article. Review.
References
- Pierik M, Yang H, Barmada MM, et al. The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflamm Bowel Dis. 2006;11:1–7. - PubMed
- Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: Lessons for complex diseases? Lancet. 2006;367:1271–84. - PubMed
- Halfvarson J, Bodin L, Tysk C, Lindberg E, Järnerot G. Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767–73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous